Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.007 per share
-
Shares outstanding
-
28.7M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
536K
-
Shares change
-
+67.9K
-
Total reported value, excl. options
-
$497K
-
Value change
-
+$62.2K
-
Number of buys
-
7
-
Number of sells
-
-3
-
Price
-
$0.91
Significant Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) as of Q4 2024
17 filings reported holding BIAF - bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share as of Q4 2024.
bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 536K shares
of 28.7M outstanding shares and own 1.87% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (261K shares), GEODE CAPITAL MANAGEMENT, LLC (99.6K shares), Sheaff Brock Investment Advisors, LLC (46.3K shares), CAPTRUST FINANCIAL ADVISORS (27.9K shares), STATE STREET CORP (17.6K shares), TWO SIGMA SECURITIES, LLC (14.4K shares), NORTHERN TRUST CORP (13.7K shares), CITADEL ADVISORS LLC (13.3K shares), Creative Planning (12.1K shares), and XTX Topco Ltd (10.6K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.